FinaleDB
FinaleDB catalogs uniformly processed, quality-controlled paired-end whole-genome sequencing (WGS) datasets of de-identified cell-free DNA (cfDNA) and provides fragmentation profiles and visualization to analyze nucleosomal protection, epigenetic modifications, and gene expression signals for biomarker and disease-mechanism research.
Key Features:
- Comprehensive Dataset Collection: Hosts thousands of uniformly processed, quality-controlled paired-end WGS cfDNA datasets derived from de-identified samples across diverse pathological conditions.
- Fragmentation Genome Browser: Visualizes and enables analysis of non-random cfDNA fragmentation patterns influenced by nucleosomal protection, epigenetic modifications, and contributing cell-type gene expression profiles.
- Integration with Omics Data: Links cfDNA fragmentation profiles with thousands of other omics datasets across different cell types to support integrative analyses of gene-regulatory landscapes.
Scientific Applications:
- Biomarker discovery and prognostic modeling: Uses cfDNA fragmentation features to support development of diagnostic and prognostic models in oncology and other diseases.
- Tissue-of-origin and gene-regulatory inference: Enables inference of contributing cell types and epigenetic/gene-expression states by relating fragmentation patterns to nucleosomal and epigenetic signals.
- Comparative and mechanistic studies: Facilitates comparative analyses of fragmentation landscapes across pathological conditions to investigate disease mechanisms.
Methodology:
Uniform processing and quality control of paired-end WGS cfDNA datasets, generation of fragmentation profiles, visualization via a fragmentation genome browser, and integration with other omics datasets.
Topics
Details
- License:
- MIT
- Tool Type:
- web application
- Programming Languages:
- JavaScript, Python, R
- Added:
- 1/18/2021
- Last Updated:
- 3/11/2021
Operations
Publications
Zheng H, Zhu MS, Liu Y. FinaleDB: a browser and database of cell-free DNA fragmentation patterns. Unknown Journal. 2020. doi:10.1101/2020.08.18.255885.